169 related articles for article (PubMed ID: 29655286)
1. Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.
Dong WW; Li J; Li J; Zhang P; Wang ZH; Sun W; Zhang H
Int J Exp Pathol; 2018 Feb; 99(1):15-21. PubMed ID: 29655286
[TBL] [Abstract][Full Text] [Related]
2. Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.
Huang Y; Dong W; Li J; Zhang H; Shan Z; Teng W
BMC Cancer; 2014 May; 14():383. PubMed ID: 24884830
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of estrogen receptor β2 is associated with different biological markers and clinicopathological factors in papillary thyroid cancer.
Dong W; Li J; Zhang H; Huang Y; He L; Wang Z; Shan Z; Teng W
Int J Clin Exp Pathol; 2015; 8(6):7149-56. PubMed ID: 26261608
[TBL] [Abstract][Full Text] [Related]
4. PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio.
Qiu YB; Liao LY; Jiang R; Xu M; Xu LW; Chen GG; Liu ZM
Sci Rep; 2019 Jan; 9(1):1032. PubMed ID: 30705367
[TBL] [Abstract][Full Text] [Related]
5. Differential expression patterns of estrogen receptor (ER)-β splice variants between papillary thyroid cancer and nodular thyroid goiter.
Dong W; Li J; Huang Y; Zhang H; Shan Z; Teng W
Med Sci Monit; 2012 Sep; 18(9):BR351-5. PubMed ID: 22936184
[TBL] [Abstract][Full Text] [Related]
6. Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma in Korea.
Ahn HY; Song RY; Ahn HS; Kim HS
Cancer Res Treat; 2021 Oct; 53(4):1204-1212. PubMed ID: 33592140
[TBL] [Abstract][Full Text] [Related]
7. Loss of ERβ expression in papillary thyroid carcinoma is associated with recurrence in young female.
Ahn HY; Kim MS; Kim MJ; Cho SY; Kim YA; Lee GH; Lee BC; Park YJ; Yi KH
Clin Endocrinol (Oxf); 2015 Feb; 82(2):300-6. PubMed ID: 24801822
[TBL] [Abstract][Full Text] [Related]
8. The estrogen receptors in the papillary carcinoma of the thyroid gland.
Vaiman M; Olevson Y; Habler L; Eviatar E; Zehari S; Sandbank J; Kessler A
Oncol Res; 2010; 18(11-12):537-40. PubMed ID: 20939429
[TBL] [Abstract][Full Text] [Related]
9. Thyroid cancer in Egypt: histopathological criteria, correlation with survival and oestrogen receptor protein expression.
Ahmed RA; Aboelnaga EM
Pathol Oncol Res; 2015 Jul; 21(3):793-802. PubMed ID: 25576212
[TBL] [Abstract][Full Text] [Related]
10. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor α induces prosurvival autophagy in papillary thyroid cancer via stimulating reactive oxygen species and extracellular signal regulated kinases.
Fan D; Liu SY; van Hasselt CA; Vlantis AC; Ng EK; Zhang H; Dong Y; Ng SK; Chu R; Chan AB; Du J; Wei W; Liu X; Liu Z; Xing M; Chen GG
J Clin Endocrinol Metab; 2015 Apr; 100(4):E561-71. PubMed ID: 25594859
[TBL] [Abstract][Full Text] [Related]
12. Expression of oestrogen-α receptor in papillary thyroid carcinoma and its association with metastasis.
Ab Halim SA; Lee SK; Mustangin M; Mohd Saleh MF; Shah SA; Md Isa N
Malays J Pathol; 2020 Dec; 42(3):415-422. PubMed ID: 33361723
[TBL] [Abstract][Full Text] [Related]
13. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
[TBL] [Abstract][Full Text] [Related]
14. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.
Chowdhury S; Veyhl J; Jessa F; Polyakova O; Alenzi A; MacMillan C; Ralhan R; Walfish PG
Oncotarget; 2016 May; 7(22):32318-28. PubMed ID: 27086918
[TBL] [Abstract][Full Text] [Related]
15. Chaperone-mediated Autophagy Governs Progression of Papillary Thyroid Carcinoma via PPARγ-SDF1/CXCR4 Signaling.
Zhou H; Xie X; Chen Y; Lin Y; Cai Z; Ding L; Wu Y; Peng Y; Tang S; Xu H
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32556197
[TBL] [Abstract][Full Text] [Related]
16. Methylation of ERβ 5'-untranslated region attenuates its inhibitory effect on ERα gene transcription and promotes the initiation and progression of papillary thyroid cancer.
Xu LW; Gou X; Yang JY; Jiang R; Jiang X; Chen GG; Liu ZM
FASEB J; 2021 Apr; 35(4):e21516. PubMed ID: 33710697
[TBL] [Abstract][Full Text] [Related]
17. Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.
Dai YJ; Qiu YB; Jiang R; Xu M; Liao LY; Chen GG; Liu ZM
Cell Oncol (Dordr); 2018 Jun; 41(3):269-282. PubMed ID: 29368272
[TBL] [Abstract][Full Text] [Related]
18. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
[TBL] [Abstract][Full Text] [Related]
19. Differential Effects of Estrogen Receptor Alpha and Beta on Endogenous Ligands of Peroxisome Proliferator-Activated Receptor Gamma in Papillary Thyroid Cancer.
Yang S; Gong Z; Liu Z; Wei M; Xue L; Vlantis AC; Zhang Y; Chan JY; van Hasselt CA; Zeng X; Qiu S; Tang N; Du J; Wei W; Tong MC; Chen GG
Front Endocrinol (Lausanne); 2021; 12():708248. PubMed ID: 34557159
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA PVT1 enhances the viability and invasion of papillary thyroid carcinoma cells by functioning as ceRNA of microRNA-30a through mediating expression of insulin like growth factor 1 receptor.
Feng K; Liu Y; Xu LJ; Zhao LF; Jia CW; Xu MY
Biomed Pharmacother; 2018 Aug; 104():686-698. PubMed ID: 29803929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
